Site-Overview.com
 

Analysis of websites containing azpicentral.com backlinks

These websites are/were linking to azpicentral.com.

 
Websites found: 32
Number of websited displayed: 32
 

List of results:

Official BYDUREON® (exenatide extended-release for injectable suspension) Healthcare Professional Website
http://site-overview.com/stats/bydureonhcp.com
Learn about once-weekly BYDUREON, the BYDUREON Pen, and how BYDUREON affected A1C levels and more in multiple clinical trials.
  • Website Address renewal date: 16/1/29
  • Domain Address Reg. date: 10/2/19
  • Website address in use until: 22/2/19
BEVESPI AEROSPHERE® (glycopyrrolate/ formoterol fumarate) Inhalation Aerosol
http://site-overview.com/stats/bevespiaerosphere.com
BEVESPI AEROSPHERE® (glycopyrrolate/ formoterol fumarate) is a long‐term, maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema.
  • Website Address renewal date: 17/8/9
  • Domain Address Reg. date: 15/8/13
  • Website address in use until: 18/8/13
BRILINTA® (ticagrelor) tablets | Heart Attack Treatment
http://site-overview.com/stats/brilinta.com
Read about BRILINTA® (ticagrelor) tablets, a prescription medication for heart attack treatment, or severe chest pain, also known as unstable angina.
  • Website Address renewal date: 17/4/17
  • Domain Address Reg. date: 05/4/21
  • Website address in use until: 18/4/21
FASENRA™ (benralizumab) Subcutaneous Injection 30 mg
http://site-overview.com/stats/fasenra.com
FASENRA™ (benralizumab) is a prescription medicine used with other asthma medicines for the maintenance treatment of asthma in adults whose asthma is not controlled with their current asthma medicines.
  • Website Address renewal date: 17/9/13
  • Domain Address Reg. date: 16/8/1
  • Website address in use until: 18/8/1
BreathABLETM | SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol
http://site-overview.com/stats/mybreathable.com
BreathABLE from SYMBICORT (budesonide/formoterol fumarate dihydrate) was created to help you control and manage difficulty breathing if you have COPD.
  • Website Address renewal date: 16/9/7
  • Domain Address Reg. date: 15/9/8
  • Website address in use until: 17/9/8
FASENRA™ (benralizumab) - Treatment Option for Eosinophilic Asthma | for HCPs
http://site-overview.com/stats/fasenrahcp.com
Learn more about the now-approved FASENRA for add-on treatment of eosinophilic asthma.
  • Website Address renewal date: 17/9/13
  • Domain Address Reg. date: 17/5/23
  • Website address in use until: 18/5/23
TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder) | HCP Site
http://site-overview.com/stats/tudorzahcp.com
Healthcare professional information on TUDORZA PRESSAIR (aclidinium bromide inhalation powder), an anticholinergic indicated for the long-term maintenance treatment of bronchospasm associated with COPD.
  • Website Address renewal date: 16/3/24
  • Domain Address Reg. date: 12/5/10
  • Website address in use until: 20/5/10
ONGLYZA® (saxagliptin) | Adult Type 2 Diabetes Medication
http://site-overview.com/stats/onglyza.com
Read information about ONGLYZA® (saxagliptin), an adult type 2 diabetes medication used with diet and exercise to help reduce A1C levels.
  • Website Address renewal date: 18/1/15
  • Domain Address Reg. date: 06/1/19
  • Website address in use until: 19/1/19
PI-Central
http://site-overview.com/stats/azpicentral.com
  • Website Address renewal date: 16/1/29
  • Domain Address Reg. date: 14/7/8
  • Website address in use until: 17/7/8
SYNAGIS® (palivizumab) Parent & Caregiver Website
http://site-overview.com/stats/synagis.com
Parent and caregiver information for SYNAGIS, a therapy to help prevent a serious lung disease caused by respiratory syncytial virus (RSV) in children at high risk for severe lung disease from RSV.
  • Website Address renewal date: 17/9/4
  • Domain Address Reg. date: 98/9/9
  • Website address in use until: 18/9/8
Acid Reflux Medication | NEXIUM® (esomeprazole magnesium)
http://site-overview.com/stats/purplepill.com
Discover NEXIUM, the Purple Pill, which offers 24-hour heartburn relief caused by acid reflux disease. Ask your doctor if NEXIUM may be right for you.
  • Website Address renewal date: 16/10/25
  • Domain Address Reg. date: 99/10/29
  • Website address in use until: 17/10/29
FARXIGA® (dapagliflozin) | Type 2 Diabetes Medication for Adults
http://site-overview.com/stats/farxiga.com
FARXIGA® (dapagliflozin) is an adult type 2 diabetes medication used with diet and exercise to improve glycemic control.
  • Website Address renewal date: 16/8/23
  • Domain Address Reg. date: 13/8/27
  • Website address in use until: 17/8/27
Official Website for BYDUREON® (exenatide extended-release) for injectable suspension
http://site-overview.com/stats/bydureonrhy15.com
Learn about BYDUREON, a non-insulin treatment option for adults with type 2 diabetes available in the BYDUREON Pen.
  • Website Address renewal date: 17/6/14
  • Domain Address Reg. date: 14/12/19
  • Website address in use until: 17/12/19
Official Website for BYDUREON® (exenatide extended-release) for injectable suspension
http://site-overview.com/stats/bydureonfin15.com
Learn about BYDUREON, a non-insulin treatment option for adults with type 2 diabetes available in the BYDUREON Pen.
  • Website Address renewal date: 17/6/14
  • Domain Address Reg. date: 14/12/19
  • Website address in use until: 17/12/19
P&T Community |
http://site-overview.com/stats/ptcommunity.com
  • Google Analytics ID: 2492160-1
  • Website Address renewal date: 15/7/22
  • Domain Address Reg. date: 02/5/20
  • Website address in use until: 17/5/20
FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) | Flu Vaccine
http://site-overview.com/stats/flumistquadrivalent.com
Help protect against seasonal flu with FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) - the flu vaccine that starts working in the nose.
  • Website Address renewal date: 16/12/2
  • Domain Address Reg. date: 11/12/6
  • Website address in use until: 17/12/6
LYNPARZA® (olaparib) | Ovarian Cancer Treatment
http://site-overview.com/stats/lynparza.com
LYNPARZA®(olaparib) is a type of targeted therapy for ovarian cancer called a PARP inhibitor. LYNPARZA may be used at different stages of ovarian cancer treatment.
  • Website Address renewal date: 16/1/29
  • Domain Address Reg. date: 14/2/10
  • Website address in use until: 19/2/10
Type 2 Diabetes Medication | BYETTA® (exenatide) injection
http://site-overview.com/stats/byetta.com
BYETTA is a non-insulin type 2 diabetes injection medication for adults.
  • Website Address renewal date: 17/1/29
  • Domain Address Reg. date: 04/2/3
  • Website address in use until: 18/2/3
IRESSA® (gefitinib) Treatment
http://site-overview.com/stats/iressa-usa.com
IRESSA® (gefitinib) is a treatment for patients.
  • Website Address renewal date: 17/6/4
  • Domain Address Reg. date: 15/6/8
  • Website address in use until: 18/6/8
PARP inhibitor for Advanced Ovarian Cancer | LYNPARZA® (olaparib)
http://site-overview.com/stats/lynparzahcp.com
LYNPARZA® (olaparib) is the first and only PARP inhibitor approved in 2 distinct settings: maintenance for recurrent ovarian cancer and following 3 or more lines of prior chemotherapy.
  • Website Address renewal date: 17/11/30
  • Domain Address Reg. date: 14/12/4
  • Website address in use until: 18/12/4
FARXIGA® (dapagliflozin) | Treatment for Type 2 Diabetes Mellitus in Adults
http://site-overview.com/stats/farxiga-hcp.com
FARXIGA® (dapagliflozin) is an SGLT2 inhibitor indicated for patients with type 2 diabetes mellitus. Explore the science behind FARXIGA.
  • Website Address renewal date: 16/9/19
  • Domain Address Reg. date: 13/9/23
  • Website address in use until: 17/9/23
SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol | Asthma & COPD Medicine
http://site-overview.com/stats/mysymbicort.com
Official patient Web site for SYMBICORT, a medicine for the treatment of asthma and COPD. Find information about the inhaler and side effects
  • Website Address renewal date: 16/7/21
  • Domain Address Reg. date: 06/7/25
  • Website address in use until: 17/7/25
MOVANTIK® (naloxegol) | Opioid Induced Constipation Treatment
http://site-overview.com/stats/movantik.com
Official Web site for MOVANTIK® (naloxegol) tablets, for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.
  • Website Address renewal date: 16/9/20
  • Domain Address Reg. date: 13/9/25
  • Website address in use until: 17/9/25
BRILINTA® (ticagrelor) tablets | Health Care Professional Web site
http://site-overview.com/stats/brilintatouchpoints.com
  • Website Address renewal date: 16/10/11
  • Domain Address Reg. date: 09/10/15
  • Website address in use until: 17/10/15
Official Website for BYDUREON® (exenatide extended-release) for injectable suspension
http://site-overview.com/stats/bydureonbybyby.com
Learn about BYDUREON, a non-insulin treatment option for adults with type 2 diabetes available in the BYDUREON Pen.
  • Website Address renewal date: 17/6/14
  • Domain Address Reg. date: 15/2/25
  • Website address in use until: 18/2/25
Type 2 Diabetes Treatment | QTERN® (dapagliflozin and saxagliptin) - For HCPs
http://site-overview.com/stats/qtern-hcp.com
Find out more about QTERN® (dapagliflozin and saxagliptin) and how it may help your patients in managing type 2 diabetes.
  • Website Address renewal date: 17/3/13
  • Domain Address Reg. date: 15/3/17
  • Website address in use until: 18/3/17
Immunotherapy for Advanced Bladder Cancer | For Patients | IMFINZI™ (durvalumab)
http://site-overview.com/stats/imfinzi.com
IMFINZI™ (durvalumab) is an immunotherapy used to treat a type of cancer in the bladder and urinary tract called urothelial carcinoma. Learn more about IMFINZI.
  • Website Address renewal date: 17/4/26
  • Domain Address Reg. date: 15/4/30
  • Website address in use until: 18/4/30
SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol For Health Care Professionals
http://site-overview.com/stats/symbicorttouchpoints.com
Official HCP site for SYMBICORT, an asthma and COPD treatment, providing information on the inhaler, side effects, dosage and prescribing information.
  • Website Address renewal date: 16/10/11
  • Domain Address Reg. date: 09/10/15
  • Website address in use until: 17/10/15
Official Website for BYDUREON® (exenatide extended-release for injectable suspension)
http://site-overview.com/stats/bydureon.com
Learn about BYDUREON® (exenatide extended-release for injectable suspension), a non-insulin treatment option for adults with type 2 diabetes available in the BYDUREON Pen.
  • Website Address renewal date: 16/1/29
  • Domain Address Reg. date: 07/11/15
  • Website address in use until: 22/11/15
MOVANTIK® (naloxegol) | Mu-Opioid Receptor Antagonist
http://site-overview.com/stats/movantikhcp.com
Official health care professional Web site for MOVANTIK® (naloxegol) tablets, for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.
  • Website Address renewal date: 16/1/29
  • Domain Address Reg. date: 14/2/14
  • Website address in use until: 19/2/14
Bipolar Disorder Medication | SEROQUEL XR® (quetiapine fumarate)
http://site-overview.com/stats/seroquelxr.com
Find information to better understand major depressive disorder (MDD), bipolar disorder, bipolar depression, and SEROQUEL XR® (quetiapine fumarate).
  • Website Address renewal date: 17/3/25
  • Domain Address Reg. date: 07/3/29
  • Website address in use until: 18/3/29
BEVESPI AEROSPHERE® (glycopyrrolate/formoterol fumarate) Inhalation Aerosol
http://site-overview.com/stats/bevespi.com
BEVESPI AEROSPHERE is a twice-daily long term treatment for adults with COPD.
  • Website Address renewal date: 17/9/28
  • Domain Address Reg. date: 14/10/2
  • Website address in use until: 18/10/2
2024-05-04 12:16:30 ... 0.0307